Amphion Innovations Plc and Amphion Innovations U.S. Inc. raised their stake in Motif Bio PLC to 22% after opting to convert the company's debt into shares.
Motif will issue 14,510,770 shares priced at 24.47 cents apiece as a result, representing a value of $3.6 million.